It is easily calculated as the total cholesterol minus the HDL cholesterol and is useful as it does not require a fasting sample. Low-density-lipoprotein cholesterol (LDL-C) is currently the primary treatment target for dyslipidemia management. However, recent studies have demonstrated that the risk for future coronary artery disease events can still remain high in patients who have achieved the guideline-recommended LDL-C target. In patients with elevated triglyceride levels, treatment of the non-HDL cholesterol is a secondary target after the LDL-C has been reached to further reduce this residual risk.
Non HDL Cholesterol (Calculated)
Non HDL Cholesterol (Calculated)
Non-HDL cholesterol measures the cholesterol content of all atherogenic lipoproteins, it is the sum of VLDL and LDL cholesterol. It is usually one of a group of tests used to investigate the health of the heart.
Non-HDL-C can provide a better risk estimation compared with LDL-C, in particular in HTG combined with diabetes, metabolic syndrome, or CKD. Elevated levels of non-HDL Cholesterol are treatable by intensifying lipid-lowering agents, as well as ongoing lifestyle modification. All of the currently available lipid-lowering agents (statins, fibrates, niacin, fish-oil products, and intestinally active agents) decrease non-HDL-C levels.
According to the ESC/EAS Guidelines for the management of dyslipidaemia, the specific target for non-HDL-C should be 0.8 mmol/L (30 mg/dL) higher than the corresponding LDL-C target; this corresponds to the LDL-C level augmented by the cholesterol fraction which is contained in 1.7 mmol/L (150 mg/dL) of TG, which is the upper limit of what is recommended.
https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/Dyslipidaemias-Management-of
There are several algorithms available to assess CVD risk and when to initiate treatment.
https://statindecisionaid.mayoclinic.org/index.php/statin/index?PHPSESSID=7t5s8vcrtmlilekvejb4pd91g4
https://academic.oup.com/eurheartj/article/41/1/111/5556353
https://www.escardio.org/Journals/ESC-Journal-Family/European-Journal-of-Preventive-Cardiology
Case Study
Delivering True Innovation
Our Services
5mL venous serum or plasma
Enfer Medical
Tests/Assays
Enfer Medical offers calculated Non-HDL Cholesterol test using Total Cholesterol and HDL cholesterol results.
Patient
Request Form
For clients using the Enfer Medical Client Portal, the Enfer Medical Patient Request Form (PRF) will be generated when you have completed your “Test Request” within the portal linked below.
Please note that samples suspected of containing high risk pathogens such as Mycobacterium tuberculosis should be clearly identified on the form and packed separately from other samples.
Results are available next working day.
This assay is available seven days a week.
Packaging
The packaging/preparation of samples for delivery to the laboratory are required to be in adherence to all national regulations for the safe transport of biological materials. HSE guidance can be reviewed HERE.
There are specific packaging instructions and labelling requirements requiring triple packaging including:
- Primary leak-proof container – tube or vial containing the sample.
- Secondary watertight container, with absorbent material, intended to protect the primary container.
- Outer container protects the secondary container.
- Patient Request forms must be placed between the secondary container and the outer shipping container.
Further information on the packaging/preparation of samples for delivery to the laboratory is contained within the Enfer Medical Laboratory User Manual which clients are provided with.
Storage & Stability
Specimens must be tested within 7 days of collection and stored at 2-8°C.
Samples
In addition to the packaging of samples, the transport/delivery of clinical samples to the laboratory is required to be in adherence to all national regulations for the safe transport of biological materials. Enfer Medical provides a fully compliant logistics service, aligned with clients’ testing requirements.
Prompt transport of specimens:
To ensure prompt testing of samples and release of results within the published test turnaround times, samples should arrive to the laboratory by 18:00. Test turnaround time is measured from receipt of the sample at the laboratory until the time the authorised results are reported to users.
of Samples
In rare cases specimens may not be suitable for testing on arrival to the laboratory. In that case the sample will be rejected at the receipt stage and the service user will be notified immediately and an explanation as to why the sample could not be processed will be provided. Reasons why samples cannot be processed include but are not limited to:
- Samples received beyond the stability limits and/or not at the correct temperature indicated for each test.
- Incorrect sample type received.
- Leaking samples, sample not received or sample insufficient for analysis as stated below within sample requirements.
- Non-compliant samples or request forms i.e. those missing sample date information, missing sample test request and/or missing sample site/type information.
- Samples received without the necessary patient identifiers.
Our Services
Quantitative results for Non HDL Cholesterol (Calculated) are reported in Numeric value in mmol/L. Please contact us for more information on the reference ranges used at Enfer Medical.
Accessing
Your Results
Following receipt at the Laboratory, results should be available on the next working day and will be reported to the referring clinician via the Enfer Medical Client Portal or in a format agreed with clients.
Established clients can login to the portal using the link above.